Join us for the European Patent Forum USA in New York and San Jose

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Join us for the European Patent Forum USA in New York and San Jose

UPC

Following the success of last year’s events we are running two more conferences on European patent reform, in New York on December 8 and San Jose on December 10. Both are free for in-house counsel

New York 2014
A panel in New York last year

The New York event takes place at Convene Times Square. It opens with an update on the Unitary Patent and Unified Patent Court. Philip Strassburger of Purdue Pharma has recently been added to this panel. Other sessions cover topics such as patent enforcement, FRAND licensing, forum shopping, opposition proceedings and alternative IP strategies.

The mix of industry and private practice speakers includes in-house counsel from IBM, Intellectual Ventures, Vringo, Shire Pharmaceuticals, Avon, Johnson & Johnson and Mondelez Global.

The San Jose event on December 10 is at the Fairmont San Jose Hotel features speakers from 3IP, Zonare, Inventergy, Google, Broadcom, Bio-Rad Laboratories and DuPont Industrial Biosciences.

Mike Willardson of SLAC National Accelerator Laboratories is the most recently added speaker.

Both days also include speakers from our sponsoring firms: Allen & Overy, Casalonga, Dechert, Dennemeyer, Marks & Clerk, Powell Gilbert, Taylor Wessing, Véron & Associés, Withers & Rogers and Wragge Lawrence Graham & Co.

More information is available here: European Patent Reform Forum, New York and European Patent Reform Forum, San Jose. You can register online, by email or phone.

more from across site and SHARED ros bottom lb

More from across our site

AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has seemingly committed to hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
With the London Annual Meeting behind us, we look back at some of the lessons learned this week and ahead to what 2027 will bring
In-house counsel aren’t impressed with law firms’ international networks, but practitioners say they are crucial for business
Gift this article